Recent discovery helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies 

Killer T cells identified in blood that can hone in on mutations uniquely expressed in cancer cells pave the way for an alternative and personalized therapeutic avenue

Findings might help predict who will react poorly to certain therapies

The expansion of immunotherapies is a key trend to watch in cancer research

Baylor researchers' work highlights that heterogeneity of both tumor cells themselves and immune composition of the microenvironment are important considerations for therapy 

Researchers found that the previous assumption that a greater diversity of tumor cells was present in more aggressive tumors was false

Flow cytometry applications in development aim to isolate cells for immunotherapy and regenerative medicine

Risk of skin cancer development cut almost 75 percent in clinical trial participants who received immunotherapy treatment

Immunotherapy treatments against cancer could reduce the amount of virus that persists in people on triple therapy

A ddPCR-based liquid biopsy can reveal whether an immunotherapy is working within weeks